Vimarsana
Biggest News Aggregation in the World

Afermine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Afermine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Afermine Today - Breaking & Trending Today

Seelos To Get License For Wafermine From IX Biopharma For $9 Mln - Vimarsana News

Seelos To Get License For Wafermine From IX Biopharma For $9 Mln

Published: November 24, 2021

WASHINGTON (dpa-AFX) - Seelos Therapeutics, Inc. (SEEL), a company focused on the development of therapies for central nervous system disorders and rare diseases, said on Wednesday that it has

Source: finanznachrichten.de
Related Topics:
United StatesHong KongRaj MehraSeelos Therapeutics IncIx Biopharma LtdYork Headquartered Seelos
iX Biopharma Ltd: iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products - Vimarsana News

iX Biopharma Ltd: iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

Published: November 24, 2021

iX Biopharma will receive an initial US$9 million upfront payment Eligible for up to US$239 million in development and sales milestone payments Double digit royalties on future product

Source: finanznachrichten.de
Related Topics:
United StatesNew YorkHong KongRaj MehraKostenloser WertpapierhandelYee Chia HsingGeddy LeeX Biopharma WaferiSeelos Therapeutics IncDrug AdministrationEuropean Medicines AgencySingapore Exchange Securities Trading LimitedIx Biopharma LtdCorporate AffairsSeelos Therapeutics Inc NasdaqSeelos TherapeuticsScientific AdviceComplex Regional Pain SyndromeLicensed Products